SCHEMBL3174840

SCHEMBL3174840

Cc1c(O)c(O)cc2c1C(=O)c1ccccc1C2=O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 4/20 0.71
▸ MCL1 Q07820 4/20 0.71
▸ MAPT P10636 6/20 0.58
▸ MEN1 O00255 5/20 0.58
▸ KMT2A Q03164 5/20 0.58
▸ ALDH1A1 P00352 4/20 0.58
▸ MAOA P21397 3/20 0.58
▸ KDM4E B2RXH2 3/20 0.58
▸ CYP3A4 P08684 3/20 0.58
▸ MAPK1 P28482 3/20 0.58
▸ RECQL P46063 3/20 0.58
▸ TTR P02766 3/20 0.58
▸ HPGD P15428 2/20 0.58
▸ ALOX15 P16050 2/20 0.58
▸ ALOX12 P18054 2/20 0.58
▸ DAPK1 P53355 2/20 0.58
▸ CYP1B1 Q16678 2/20 0.58
▸ HSD17B10 Q99714 2/20 0.58
▸ BRCA1 P38398 2/20 0.58
▸ TDP1 Q9NUW8 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18601896 0.86 ELANE (0.59) BCL2MCL1MAPTMEN1KMT2A
Rubiadin SCHEMBL1426928 0.86 BCL2 (0.71) BCL2MCL1MAPTMEN1KMT2A
Rubiadin SCHEMBL29665059 0.86 BCL2 (0.71) BCL2MCL1MAPTMEN1KMT2A
Rubiadin SCHEMBL30260037 0.86 BCL2 (0.71) BCL2MCL1MAPTMEN1KMT2A
Rubiadin SCHEMBL22616292 0.86 BCL2 (0.71) BCL2MCL1MAPTMEN1KMT2A
SCHEMBL3191858 0.85 ELANE (0.67) BCL2MCL1MAPTMEN1KMT2A
SCHEMBL555230 0.83 BCL2 (1.00) BCL2MCL1MAPTMEN1KMT2A
SCHEMBL29388375 0.83 BCL2 (1.00) BCL2MCL1MAPTMEN1KMT2A
SCHEMBL29384381 0.83 BCL2 (1.00) BCL2MCL1MAPTMEN1KMT2A
Methoxymethane SCHEMBL9852502 0.81 BCL2 (0.86) BCL2MCL1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7658937-B2 Anthraquinones and process for the preparation and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2010-02-09 — — US claimed
CN-101426506-A Novel anthraquinones and process for the preparation and method of use thereof UNIV MICHIGAN (US) 2009-05-06 — — CN claimed
US-20050267307-A1 Novel anthraquinones and process for the preparation and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2005-12-01 — — US claimed
CN-110522808-A A kind of anti-treating caput femoris necrosis Chinese medicine composition and preparation method thereof YIWU LINGCHUAN TECH CO LTD 2019-12-03 — — CN disclosed
CN-108295591-A Pollution cleanup composition based on plant extracts 国润生物科技(深圳)有限公司 2018-07-20 — — CN disclosed
CN-108261861-A Clarifying smoke composition 国润生物科技(深圳)有限公司 2018-07-10 — — CN disclosed
CN-107397967-A Can effectively solve the air purifying preparation of parking facility air pollutants 王婧宁 2017-11-28 — — CN disclosed
CN-107297128-A Can the new decorating house of fast purification air freshener 王婧宁 2017-10-27 — — CN disclosed
CN-106943228-A Traditional Chinese medicine physiotherapy waist support waistband 彭锐 2017-07-14 — — CN disclosed
CN-104688927-A Paste formula for invigorating kidney and nourishing essence Xintai hospital of traditional chinese medicine 2015-06-10 — — CN disclosed
CN-104304539-A Cancer-eliminating tea containing flavonoid compounds and preparation method thereof ZHOU JICHUN 2015-01-28 — — CN disclosed
CN-104138496-A Pills for treating dysuria of the old SHANGHAI PUDONG GAOXING BIOTECHNOLOGY RES INST 2014-11-12 — — CN disclosed
US-7658937-B2 Anthraquinones and process for the preparation and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2010-02-09 — — US disclosed
US-7658937-B2 Anthraquinones and process for the preparation and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2010-02-09 — — US disclosed
CN-101426506-A Novel anthraquinones and process for the preparation and method of use thereof UNIV MICHIGAN (US) 2009-05-06 — — CN disclosed
CN-101356996-A Preparation method of water extract of morinda root and use thereof in cigarette LONGYAN TOBACCO INDUSTRY CO LT (CN) 2009-02-04 — — CN disclosed
CN-101356997-A Preparation method of alcohol extract of morinda root and use thereof in cigarette LONGYAN TOBACCO INDUSTRY CO LT (CN) 2009-02-04 — — CN disclosed
EP-1745000-A2 NOVEL ANTHRAQUINONES AND PROCESS FOR THE PREPARATION AND METHOD OF USE THEREOF Michigan State University (US) 2007-01-24 — — EP disclosed
US-20050267307-A1 Novel anthraquinones and process for the preparation and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2005-12-01 — — US disclosed
WO-2005113478-A2 NOVEL ANTHRAQUINONES AND PROCESS FOR THE PREPARATION AND METHOD OF USE THEREOF MICHIGAN STATE UNIVERSITY (US) 2005-12-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050267307-A1 Novel anthraquinones and process for the preparation and method of use thereof PAH, APEH, SDHA BCL2 2400/4885MCL1 1804/4885MAPT 3904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback